MELISSA BRINKMAN: Open Payments
NPI 1932655271 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,647 in 81 payments from 23 companies in 2025. Trend: 2023 $1,804 · 2024 $2,514 · 2025 $1,647
Food & beverage: $1,647
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $337 |
| ABBVIE INC. | 17 | $246 |
| Novo Nordisk Inc | 9 | $155 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $150 |
| PFIZER INC. | 5 | $106 |
| Lilly USA, LLC | 6 | $103 |
| Astellas Pharma US Inc | 3 | $64 |
| Otsuka America Pharmaceutical, Inc. | 4 | $58 |
| Exact Sciences Corporation | 3 | $55 |
| Actelion Pharmaceuticals US, Inc. | 1 | $42 |
Products named: AIRSUPRA, JARDIANCE, QULIPTA, MOUNJARO, Wegovy, NURTEC ODT, Veozah, VRAYLAR.
Industry payments across OH — which companies pay providers there.
